Type of Care:
Mental health treatment Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.):
Residential/24-hour residential
Facility Type:
Residential treatment center (RTC) for children
Pharmacotherapies:
Haloperidol Loxapine Thioridazine Aripiprazole Clozapine Lurasidone Olanzapine Olanzapine/Fluoxetine combination Paliperidone Quetiapine Risperidone Ziprasidone Nicotine replacement Non-nicotine smoking/tobacco cessation Antipsychotics used in treatment of SMI
Treatment Approaches:
Activity therapy Cognitive behavioral therapy Couples/family therapy Dialectical behavior therapy Eye Movement Desensitization and Reprocessing therapy Group therapy Individual psychotherapy Telemedicine/telehealth therapy Abnormal involuntary movement scale
Emergency Mental Health Services:
Psychiatric emergency onsite services
Facility Operation (e.g., Private, Public):
Private non-profit organization
Assessment/Pre-treatment:
Screening for tobacco use
Testing:
Metabolic syndrome monitoring Laboratory testing
Recovery Support Services:
Mentoring/peer support
Education and Counseling Services:
Smoking/vaping/tobacco cessation counseling
Facility Smoking Policy :
Smoking not permitted
Age Groups Accepted:
Children/Adolescents
Language Services:
Sign language services for the deaf and hard of hearing
Facility Vaping Policy:
Vaping not permitted
Ancillary Services:
Court-ordered outpatient treatment Diet and exercise counseling Vocational rehabilitation services Case management service Suicide prevention services Education services